Could a One-Time high dose beat daily shots for histoplasmosis?
NCT ID NCT07261150
First seen Jan 05, 2026 · Last updated May 20, 2026 · Updated 15 times
Summary
This study tests if a single high dose of an IV antifungal works as well as the standard daily dose for treating moderate to severe histoplasmosis, a serious lung infection. It also compares two oral medications and shorter treatment duration (6 vs 12 months) for people with HIV. The trial aims to find safer, more effective, and simpler treatment options for 664 hospitalized adults.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HISTOPLASMOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universidade Federal de Ciências da Saúde de Porto Alegre
Porto Alegre, Brazil
Contact Email: •••••@•••••
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.